Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bicknell

Showing results (91-100 of 190) with videos related to

Pageof 19
Sort By:
Cancer Research|February 1, 1995
Different angiogenic pathways characterize superficial and invasive bladder cancerT O'Brien, D Cranston, S Fuggle, et al.
Cancer Research|June 1, 1996
The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancersT O'Brien, D Cranston, S Fuggle, et al.
Human Gene Therapy|February 4, 1998
Endothelial cell-specific expression of tumor necrosis factor-alpha from the KDR or E-selectin promoters following retroviral deliveryR T Jaggar, H Y Chan, A L Harris, et al.
Cancer Research|January 1, 1997
Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancerT O'Brien, D Cranston, S Fuggle, et al.
Human Reproduction (Oxford, England)|March 1, 2002
In-vivo angiogenesis and progestogensS Hague, I Z MacKenzie, R Bicknell, et al.
Transplantation Proceedings|June 24, 1998
Is TGF-beta a profibrotic cytokine in human renal transplants?M L Nicholson, G R Bicknell, S T Williams, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 11, 2003
Differential effects of modern immunosuppressive agents on the development of intimal hyperplasiaJulian R Waller, Nicholas R Brook, Gareth R Bicknell, et al.
Cancer Research|December 5, 2000
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factorsN S Brown, A Jones, C Fujiyama, et al.
Transplantation Proceedings|April 6, 2005
The novel antifibrotic agent pirfenidone attenuates the profibrotic environment generated by calcineurin inhibitors in the rat salt-depletion modelN R Brook, J R Waller, G R Bicknell, et al.
Transplantation Proceedings|April 6, 2005
Prograf produces a molecular environment favoring antifibrosis, an effect reversed by the addition of rapamuneN R Brook, J R Waller, G R Bicknell, et al.
Pageof 19

Showing results (91-100 of 190) with videos related to

Sort By:
Pageof 19
Cancer Research|February 1, 1995
Different angiogenic pathways characterize superficial and invasive bladder cancerT O'Brien, D Cranston, S Fuggle, et al.
Cancer Research|June 1, 1996
The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancersT O'Brien, D Cranston, S Fuggle, et al.
Human Gene Therapy|February 4, 1998
Endothelial cell-specific expression of tumor necrosis factor-alpha from the KDR or E-selectin promoters following retroviral deliveryR T Jaggar, H Y Chan, A L Harris, et al.
Cancer Research|January 1, 1997
Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancerT O'Brien, D Cranston, S Fuggle, et al.
Human Reproduction (Oxford, England)|March 1, 2002
In-vivo angiogenesis and progestogensS Hague, I Z MacKenzie, R Bicknell, et al.
Transplantation Proceedings|June 24, 1998
Is TGF-beta a profibrotic cytokine in human renal transplants?M L Nicholson, G R Bicknell, S T Williams, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 11, 2003
Differential effects of modern immunosuppressive agents on the development of intimal hyperplasiaJulian R Waller, Nicholas R Brook, Gareth R Bicknell, et al.
Cancer Research|December 5, 2000
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factorsN S Brown, A Jones, C Fujiyama, et al.
Transplantation Proceedings|April 6, 2005
The novel antifibrotic agent pirfenidone attenuates the profibrotic environment generated by calcineurin inhibitors in the rat salt-depletion modelN R Brook, J R Waller, G R Bicknell, et al.
Transplantation Proceedings|April 6, 2005
Prograf produces a molecular environment favoring antifibrosis, an effect reversed by the addition of rapamuneN R Brook, J R Waller, G R Bicknell, et al.
Pageof 19